Delivery Order SPE2DB20D3104-SPE2DB25FV8L1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Ondansetron ODT 8 mg tablets in a quantity of 30-count packages, with a ceiling value of $1,733.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the delivery is scheduled for completion by June...
- The Defense Logistics Agency awarded a delivery order valued at $35,913.34 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with the contractor's corporate headquarters location. The award represents a...
- The Defense Logistics Agency awarded a $19,211.98 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) under a firm fixed price contract. The award was made competitively with no set-aside designation on April 24, 2025, with completion expected by April 25, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $7,527.37 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units) with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a $2,487.53 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 21, 2025, with completion targeted for August 22, 2025. This firm fixed-price, non-set-aside delivery order is being performed in Conshohocken, Pennsylvania, the vendor's corporate headquarters location. The award represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio to federal customers. This...
- The Defense Logistics Agency awarded a $5,957.27 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. This competitively awarded, firm fixed-price contract requires delivery by September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting the company's demonstrated capability to compete in open...
- The Defense Logistics Agency awarded a delivery order valued at $1,911.13 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) with an ultimate completion date of June 2, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $8,939.49 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count packages) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,227.22 for Ondansetron ODT 8 mg tablets (30-count packaging) on July 11, 2025, with an ultimate completion date of July 14, 2025. This competitively awarded, non-set-aside delivery order represents a firm fixed price transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $18,470.50 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV8L1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,783.48 to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units). The contract is a firm fixed-price delivery order with a completion date of June 26, 2025, and is being performed at the contractor's location in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded through the federal procurement process. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves as a critical federal vendor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet diverse medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 6/25/25 |